Inhaled bronchodilator therapy in mechanically ventilated patients

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 1, 1997, Pages 3-10

  Dhand, Rajiv ^a,b   Tobin, Martin J ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b HINES VA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; FENOTEROL; IPRATROPIUM BROMIDE; ISOETARINE; ISOPRENALINE; ORCIPRENALINE; SALBUTAMOL;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; AIRWAY OBSTRUCTION; ARTIFICIAL VENTILATION; ASTHMA; BRONCHODILATATION; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ENDOTRACHEAL TUBE; HEART ARRHYTHMIA; HEAT; HUMAN; HUMIDIFIER; INFANT; INHALATIONAL DRUG ADMINISTRATION; METERED DOSE INHALER; NEBULIZER; NEWBORN; PARTICLE SIZE; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW;

EID: 0030845450     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.1.9610025     Document Type: Review

References (78)

1. Gross, N. J., J. W. Jenne, and D. Hess. 1994. Bronchodilator therapy. In M. J. Tobin, editor. Principles and Practice of Mechanical Ventilation. McGraw-Hill, New York. 1077-1123.
2. Manthous, C. A., J. B. Hall, G. A. Schmidt, and L. D. H. Wood. 1993. Metered-dose inhaler versus nebulized albuterol in mechanically ventilated patients. Am. Rev. Respir. Dis. 148:1567-1570.
3. Newhouse, M. T., and H. D. Fuller. 1993. Rose is a rose is a rose? Aerosol therapy in ventilated patients: nebulizers versus metered dose inhalers - a continuing controversy (editorial). Am. Rev. Respir. Dis. 148: 1444-1446.
4. Manthous, C. A., W. Chatila, G. A. Schmidt, and J. B. Hall. 1995. Treatment of bronchospasm by metered-dose inhaler albuterol in mechanically ventilated patients. Chest 107:210-213.
5. Dhand, R., A. Jubran, and M. J. Tobin. 1995. Bronchodilator delivery by metered-dose inhaler in ventilator-supported patients. Am. J. Respir. Crit. Care Med. 151:1827-1833.
6. Dhand, R., A. G. Duarte, A. Jubran, J. W. Jenne, J. B. Fink, P. J. Fahey, and M. J. Tobin. 1996. Dose response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients. Am. J. Respir. Crit. Care Med. 154:388-393.
7. Dhand, R., and M. J. Tobin. 1996. Bronchodilator delivery with metered-dose inhalers in mechanically-ventilated patients. Eur. Respir. J. 9:585-595.
8. Ilowite, J. S., and A. M. Fein. 1996. Aerosol therapy. In A. R. Leff, editor. Pulmonary and Critical Care Pharmacology and Therapeutics. McGraw-Hill, New York. 1129-1137.
9. Fuller, H. D., M. B. Dolovich, C. Chambers, and M. T. Newhouse. 1992. Aerosol delivery during mechanical ventilation: a predictive in vitro lung model. J. Aerosol Med. 5:251-259.
10. O'Riordan, T. G., M. J. Greco, R. J. Perry, and G. C. Smaldone. 1992. Nebulizer function during mechanical ventilation. Am. Rev. Respir. Dis. 145:1117-1122.
11. O'Doherty, M. J., S. H. L. Thomas, C. J. Page, D. F. Treacher, and T. O. Nunan. 1992. Delivery of a nebulized aerosol to a lung model during mechanical ventilation: effect of ventilator settings and nebulizer type, position, and volume of fill. Am. Rev. Respir. Dis. 146:383-388.
12. Thomas, S. H. L., M. J. O'Doherty, C. J. Page, D. F. Treacher, and T. O. Nunan. 1993. Delivery of ultrasonic nebulized aerosols to a lung model during mechanical ventilation. Am. Rev. Respir. Dis. 148:872-877.
13. Diot, P., L. Morra, and G. C. Smaldone. 1995. Albuterol delivery in a model of mechanical ventilation: comparison of metered-dose inhaler and nebulizer efficiency. Am. J. Respir. Crit. Care Med. 152:1391-1394.
14. Rau, J. L., R. J. Harwood, and J. L. Groff. 1992. Evaluation of a reservoir device for metered-dose bronchodilator delivery to intubated adults: an in vitro study. Chest 102:924-930.
15. Taylor, R. H., J. Lerman, C. Chambers, and M. Dolovich. 1993. Dosing efficiency and particle-size characteristics of pressurized metered-dose inhaler aerosols in narrow catheters. Chest 103:920-924.
16. Fink, J. B., R. Dhand, A. G. Duarte, J. W. Jenne, and M. J. Tobin. 1996. Deposition of aerosol from metered-dose inhaler during mechanical ventilation: an in vitro model. Am. J. Respir. Crit. Care Med. 154:382-387.
17. Ahrens, R. C., R. A. Ries, W. Popendorf, and J. A. Wiese. 1986. The delivery of therapeutic aerosols through endotracheal tubes. Pediatric Pulmonol. 2:19-26.
18. Crogan, S. J., and M. J. Bishop. 1989. Delivery efficiency of metered dose aerosols given via endotracheal tubes. Anesthesiology 70:1008-1010.
19. Dhand, R., S. K. Malik, M. Balakrishan, and S. R. Verma. 1988. High speed photographic analysis of aerosols produced by metered-dose inhalers. J. Pharm. Pharmacol. 40:429-430.
20. Garner, S. S., D. B. Wiest, and J. W. Bradley. 1994. Albuterol delivery by metered-dose inhaler with a pediatric mechanical ventilatory circuit model. Pharmacotherapy 14:210-214.
21. Svartengren, M., M. Anderson, K. Philipson, and P. Camner. 1989. Human lung deposition of particles suspended in air or in helium/oxygen mixture. Exp. Lung. Res. 15:575-585.
22. Anderson, M., M. Svartengren, G. Bylin, K. Philipson, and P. Camner. 1993. Deposition in asthmatics of particles inhaled in air or in helium-oxygen. Am. Rev. Respir. Dis. 147:524-528.
23. Hughes, J. M., and J. Saez. 1987. Effects of nebulizer mode and position in a mechanical ventilator circuit on dose efficiency. Respir. Care 32: 1131-1135.
24. Harvey, C. J., M. J. O'Doherty, C. J. Page, S. H. L. Thomas, T. O. Nunan, and D. F. Treacher. 1995. Effect of a spacer on pulmonary aerosol deposition from a jet nebulizer during mechanical ventilation. Thorax 50:50-53.
25. Bishop, M. J., R. P. Larson, and D. L. Buschman. 1990. Metered dose inhaler aerosol characteristics are affected by the endotracheal tube actuator/adapter used. Anesthesiology 73:1263-1265.
26. Fuller, H. D., M. B. Dolovich, F. H. Turpie, and M. T. Newhouse. 1994. Efficiency of bronchodilator aerosol delivery to the lungs from the metered dose inhaler in mechanically ventilated patients: a study comparing four different actuator devices. Chest 105:214-218.
27. Niven, R. W., R. M. Kacmarek, J. D. Brain, and R. A. Peterfreund. 1993. Small bore nozzle extensions to improve the delivery efficiency of drugs from metered-dose inhalers: laboratory evaluation. Am. Rev. Respir. Dis. 147:1590-1594.
28. Spahr-Schopfer, I. A., J. Lerman, E. Cutz, M. T. Newhouse, and M. Dolovich. 1994. Proximate delivery of a large experimental dose from salbutamol MDI induces epithelial airway lesions in intubated rabbits. Am. J. Respir. Crit. Care Med. 150:790-794.
29. Fink, J., R. Dhand, P. Fahey, and M. J. Tobin. 1996. Exhaled aerosol accounts for differences between in vitro and in vivo delivery from a metered-dose inhaler during mechanical ventilation (abstract). Am. J. Respir. Crit. Care Med. 153:A377.
30. Moren, F., and J. Andersson. 1980. Fraction of dose exhaled after administration of pressurized inhalation aerosols. Int. J. Pharmaceutics 6:295-300.
31. O'Riordan, T. G., L. B. Palmer, and G. C. Smaldone. 1994. Aerosol deposition in mechanically ventilated patients: optimizing nebulizer delivery. Am. J. Respir. Crit. Care Med. 149:214-219.
32. Fuller, H. D., M. B. Dolovich, G. Posmituck, W. Wong Pack, and M. T. Newhouse. 1990. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients: comparison of dose to the lungs. Am. Rev. Respir. Dis. 141:440-444.
33. Thomas, S. H. L., M. J. O'Doherty, H. M. Fidler, C. J. Page, D. F. Treacher, and T. O. Nunan. 1993. Pulmonary deposition of a nebulized aerosol during mechanical ventilation. Thorax 48:154-159.
34. MacIntyre, N. R., R. M. Silver, C. W. Miller, F. Schuler, and E. R. Coleman. 1985. Aerosol delivery in intubated, mechanically ventilated patients. Crit. Care Med. 13:81-84.
35. Newman, S. P. 1983. Therapeutic aerosol deposition in man. In F. Moren, M. B. Dolovich, M. T. Newhouse, and S. P. Newman. editors. Aerosols in Medicine, 2nd rev. ed. Elsevier, Amsterdam. 375-399.
36. Tan, Y. K., and S. J. Soldin. 1984. Determination of salbutamol in human serum by reversed-phase high-performance liquid chromatography with amperometric detection. J. Chromatog. A. 311:311-317.
37. Gupta, R. N., H. D. Fuller, and M. B. Dolovich. 1994. Optimization of a column liquid chromatographic procedure for the determination of plasma salbutamol concentration. J. Chromatog. B. Biomed. Appl. 654: 205-211.
38. Duarte, A. G., R. Dhand, R. Reid, M. J. Tobin, and J. W. Jenne. 1996. Serum albuterol levels after metered-dose inhaler administration to ventilated patients and healthy controls. Am. J. Respir. Crit. Care Med. 154:1658-1663.
39. Boucher, B. A., D. A. Kuhl, B. C. Coffey, and T. C. Fabian. 1990. Drug use in a trauma intensive care unit. Am. J. Hosp. Pharm. 47:805-810.
40. Wegener, T., S. Wretman, B. Sandhagen, and S.-O. Nystrom. 1987. Effect of ipratropium bromide aerosol on respiratory function in patients under ventilator treatment. Acta Anaesthesiol. Scand. 31:652-654.
41. Bernasconi, M., R. Brandolese, R. Poggi, E. Manzin, and A. Rossi. 1990. Dose-response effects and time course of effects of inhaled fenoterol on respiratory mechanics and arterial oxygen tension in mechanically ventilated patients with chronic airflow obstruction. Intensive Cure Med. 16:108-114.
42. Fernandez, A., A. Lazaro, A. Garcia, C. Aragon, and E. Cerda. 1990. Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation: utilization of metered-dose inhalers. Am. Rev. Respir. Dis. 141:164-168.
43. Yang, S. C., S. P. Yang, and T. S. Lee. 1994. Nebulized ipratropium bromide in ventilator-assisted patients with chronic bronchitis. Chest 105: 1511-1515.
44. Fresoli, R. P., R. M. Smith, J. A. Young, and S. C. Gotshall. 1968. Use of aerosol isoproterenol in an anesthesia circuit. Anesth. Analg. 47:127-132.
45. Gold, M. I. 1975. Treatment of bronchospasm during anesthesia. Anesth. Analg. 54:783-786.
46. Sprague, D. H. 1977. Treatment of intraoperative bronchospasm with nebulized isoetharine. Anesthesiology 46:222-224.
47. Corbridge, T., and J. B. Hall. 1996. Pharmacotherapy of status asthmaticus. In A. R. Leff, editor. Pulmonary and Critical Care Pharmacology and Therapeutics. McGraw-Hill, New York. 773-781.
48. Gay, P. C., J. R. Rodarte, M. Tayyab, and R. D. Hubmayr. 1987. Evaluation of bronchodilator responsiveness in mechanically ventilated patients. Am. Rev. Respir. Dis. 136:880-885.
49. Wright, P. E., L. C. Carmichael, and G. R. Bernard. 1994. Effects of bronchodilators on lung mechanics in the acute respiratory distress syndrome (ARDS). Chest 106:1517-1523.
50. Bates, J. H. T., and J. Milic-Emili. 1991. The flow interruption technique for measuring respiratory resistance. J. Crit. Care 6:227-238.
51. Bates, J. H. T., A. Rossi, and J. Milic-Emili. 1985. Analysis of the behavior of the respiratory system with constant inspiratory flow. J. Appl. Physiol. 58:1840-1848.
52. Jackson, A. C., H. T. Milhorn, Jr., and J. R. Norman. 1974. A reevaluation of the interrupter technique for airway resistance measurement. J. Appl. Physiol. 36:264-268.
53. Pepe, P. E., and J. J. Marini. 1982. Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction. Am. Rev. Respir. Dis. 126:166-170.
54. Fernandez, A., J. Munoz, B. de la Calle, I. Alia, A. Ezpeleta, M. A. de la Cal, and A. Reyes. 1994. Comparison of one versus two bronchodilators in ventilated COPD patients. Intensive Care Med. 20:199-202.
55. Gay, P. C., H. G. Patel, S. B. Nelson, B. Gilles, and R. D. Hubmayr. 1991. Metered dose inhalers for bronchodilator delivery in intubated, mechanically ventilated patients. Chest 99:66-71.
56. Craven, D. E., D. A. Lichtenberg, T. A. Goularte, B. J. Make, and W. R. McCabe. 1984. Contaminated medication nebulizers in mechanical ventilator circuits: source of bacterial aerosols. Am. J. Med. 77:834-838.
57. Hamill, R. J., E. D. Houston, P. R. Georghiu, C. E. Wright, M. A. Koza, R. M. Cadle, P. A. Goepfert, D. A. Lewis, G. J. Zenon, and J. E. Clarridge. 1995. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann. Intern. Med. 122:762-766.
58. Beaty, C. D., R. H. Ritz, and M. S. Benson. 1989. Continuous in-line nebulizers complicate pressure support ventilation. Chest 96:1360-1363.
59. Alvine, G. F., P. Rodgers, K. M. Fitzsimmons, and R. C. Ahrens. 1992. Disposable jet nebulizers: how reliable are they? Chest 101:16-19.
60. Summer, W., R. Elston, L. Tharpe, S. Nelson, and E. F. Haponik. 1989. Aerosol bronchodilator delivery methods: relative impact on pulmonary function and cost of respiratory care. Arch. Intern. Med. 149:618-623.
61. Bowton, D. L., W. M. Goldsmith, and E. F. Haponik. 1992. Substitution of metered-dose inhalers for hand-held nebulizers: success and cost savings in a large, acute-care hospital. Chest 101:305-308.
62. Cameron, D., M. Clay, and M. Silverman. 1990. Evaluation of nebulizers for use in neonatal ventilator circuits. Crit. Care Med. 18:866-870.
63. Fok, T. F., S. Monkman, M. Dolovich, S. Gray, G. Coates, B. Paes, F. Rashid, M. Newhouse, and H. Kirpalani. 1996. Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Pediatr. Pulmonol. 21:301-309.
64. Wilkie, R. A., and M. H. Bryan. 1987. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease. J. Pediatr. 111:278-282.
65. Motoyama, E. K., M. D. Fort, K. W. Klesh, R. L. Mutich, and R. D. Guthrie. 1987. Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia. Am. Rev. Respir. Dis. 136:50-57.
66. Denjean, A., H. Guimaraes, M. Migdal, J. L. Miramand, M. Dehann, and C. Gaultier. 1992. Dose-related bronchodilator response to aerosolized salbutamol (albuterol) in ventilator-dependent premature infants. J. Pediatr. 120:974-979.
67. Giep, T., P. Raibble, T. Zuerlein, and I. D. Schwartz. 1996. Trial of beclomethasone dipropionate by metered-dose inhaler in ventilator-dependent neonates less than 1500 grams. Am. J. Perinatol. 13:5-9.
68. Arnon, S., J. Grigg, and M. Silverman. 1996. Effectiveness of budesonide aerosol in ventilator-dependent premature babies: a preliminary report. Pediatr. Pulmonol. 21:231-235.
69. Kung, M., S. W. Croley, and B. A. Phillips. 1987. Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol: influence of mouth rinsing and gargling. Chest 91: 382-387.
70. Breeden, C. C., and B. H. Safirstein. 1990. Albuterol and spacer-induced atrial fibrillation. Chest 98:762-763.
71. Higgins, R. M., W. O. C. M. Cookson, D. J. Lane, S. M. John, G. L. McCarthy, and S. T. McCarthy. 1987. Cardiac arrhythmias caused by nebulized beta-agonist therapy. Lancet 2:863-864.
72. Newhouse, M. T., K. R. Chapman, A. L. McCallum, R. T. Abboud, D. M. Bowie, R. V. Hodder, P. D. Pare, H. Mesic-Fuchs, and N. A. Molfino. 1996. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma. Chest 110:595-603.
73. Papo, M. C. J. Frank, and A. E. Thompson. 1993. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit. Care Med. 21:1479-1486.
74. Shrestha, M., K. Bidadi, S. Gourlay, and J. Hayes. 1996. Continuous vs. intermittent albuterol, at high and low doses, in the treatment of severe acute asthma in adults. Chest 110:42-47.
75. Silverglade, A. 1972. Cardiac toxicity of aerosol propellants. J.A.M.A. 222:827-829.
76. Dollery, C. T., F. M. Williams, G. H. Draffan, G. Wise, H. Sahyoun, G. W. Paterson, and S. R. Walker. 1974. Arterial blood levels of fluorocarbons in asthmatic patients. Clin. Pharmacol. Ther. 15:59-66.
77. Tobin, M. J., and W. B. Van de Graaff. 1994. Monitoring of lung mechanics and work of breathing. In M. J. Tobin, editor. Principles and Practice of Mechanical Ventilation. McGraw-Hill, New York. 967-1003.
78. Shalansky, K. F., E. Y. F. Htan, D. M. Lyster, B. Mouat, and M. G. Tweeddale. 1993. In vitro evaluation of the effect of metered-dose inhaler administration technique on aerosolized drug delivery. Pharmacotherapy 13:233-238.